20.06.2016 - Auditorium dell'Università della Svizzera Italiana, Lugano
Basic and translational research on stem cells for regenerating injured organs, including the heart and the brain, has experienced tremendous progress over the past decade.
Besides cell types traditionally used in regenerative protocols, such as bone marrow-derived cells and mesenchymal stem cells, new candidate cell types for cardiac repair have emerged, most notably cardiac-resident stem and progenitor cells.
Meanwhile, induced pluripotent stem (iPS) cells provide a unique opportunity of disease modelling and personalized medicine. The roles of molecular mediators of stem cell effects, such as paracrine factors including exosomes and noncoding RNA, are increasingly well understood and exploited in therapeutic strategies.
The fifth edition of the Lugano Stem Cell Meeting provides a unique opportunity to discuss the above scientific issues with worldwide leaders in the field within a particularly comfortable context.
As for the previous editions of the Meeting, the first day will be focused on basic research while the second day will be more specifically devoted to clinical applications and cell therapy trials.
Spotlight sessions of this edition will highlight exosomes as paracrine mediators of functional effects of stem cells, noncoding RNA as critical regulators of cell function, and stem cell-based approaches for the treatment of neurological diseases.
